B cell involvement in the pathogenesis of ankylosing spondylitis

R Wilbrink, A Spoorenberg, GMPJ Verstappen… - International journal of …, 2021 - mdpi.com
Extensive research into ankylosing spondylitis (AS) has suggested the major role of
genetics, immune reactions, and the joint–gut axis in its etiology, although an ultimate …

Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic …

R Taha, H El-Haddad, A Almuallim… - … research and reviews, 2017 - Taylor & Francis
Rituximab (RTX) is established for the treatment of rheumatoid arthritis. This systematic
review of the literature since 2006 summarizes evidence for the use of RTX in the treatment …

Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population

S Zhao, H Zhou, X Peng, J Zhu, W Wang… - Journal of the …, 2016 - Elsevier
Purpose This study retrospectively reviewed the clinical features of optic neuritis (ON) with
positive HLA-B27. Method Clinical data were reviewed for HLA-B27-positive ON in the …

Seropositive neuromyelitis optica in a case of undiagnosed ankylosing spondylitis: a neuro-rheumatological conundrum

R Ghosh MD, D Roy, M León-Ruiz, S Das… - Qatar Medical …, 2022 - qscience.com
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy against
foot processes of aquaporin-4 (AQP4) water channels. Patients with NMOSD tend to have …

Use of rituximab to treat a patient with coexistence of rheumatoid arthritis and ankylosing spondylitis: 18 months follow‐up

U Dundar, H Cevik, US Demirdal… - International Journal of …, 2018 - Wiley Online Library
Coexistence of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) is rare. Tumor
necrosis factor (TNF) inhibitor has been highly successful in controlling inflammation in …

Coexistence of multiple sclerosis and ankylosing spondylitis: report of two cases

A Lourbopoulos, P Ioannidis, E Boura… - European …, 2013 - karger.com
Background: Multiple sclerosis (MS) only rarely coexists with ankylosing spondylitis (AS).
The optimal management of these patients represents a major challenge. Methods: In the …

B cell involvement in the pathogenesis of axial spondyloarthritis

R Wilbrink - 2025 - research.rug.nl
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that pre-dominantly affects
the spine and sacroiliac joints, causing pain, stiffness, and diminished spinal mobility. The …

Sixteen syndrome: a rare presentation of central demyelination

F Bridge, T Bennett, K Buzzard - BMJ Case Reports CP, 2023 - casereports.bmj.com
This case illustrates two diagnostic challenges for clinicians: the rarely described sixteen
syndrome and the relationship between tumour necrosis factor (TNF)-alpha inhibitors and …

Etanercept for ankylosing spondylitis with coexisting demyelinating myelitis

C Ye, Z Geng, S Li, F Yu - American Journal of Therapeutics, 2019 - journals.lww.com
To the Editor: Ankylosing spondylitis (AS) is an inflammatory rheumatic disease that
predominantly affects the axial skeleton and causes characteristic inflammatory back pain …

[PDF][PDF] What is the effect of accompanying ankylosing spondylitis in treatment of Multiple Sclerosis? Is there a resistance

EA Tezcan, H Ekmekçi, G Özdemir, H Gümüş, Ş Öztürk - 2019 - jag.journalagent.com
Multiple sclerosis (MS) is an autoimmune central nervous system disease characterized by
inflammation, demyelination, and axonal damage (1). Ankylosing spondylitis (AS) is a …